CC
Craig C. Hopkinson sold $423K of ALKS stock
Craig C. Hopkinson, EVP R&D, Chief Medical Officer of Alkermes plc. (ALKS), sold 9,000 shares of ALKS stock worth $423K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Sep 1, 2026.
ALKS has moved -4.8% since the trade date, from $47.20 to $44.94 (Nov 20, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 0 days
- Price since
- -4.8%
- Role
- EVP R&D, Chief Medical Officer
- Source
- SEC Form 4